Cartesian Therapeutics Statistics
Total Valuation
RNAC has a market cap or net worth of $269.41 million. The enterprise value is $105.76 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, before market open.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
RNAC has 25.95 million shares outstanding. The number of shares has increased by 326.98% in one year.
| Current Share Class | 25.95M |
| Shares Outstanding | 25.95M |
| Shares Change (YoY) | +326.98% |
| Shares Change (QoQ) | +1.89% |
| Owned by Insiders (%) | 58.46% |
| Owned by Institutions (%) | 27.91% |
| Float | 9.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.49 |
| Forward PS | 95.77 |
| PB Ratio | -12.49 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.09 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.34
| Current Ratio | 12.34 |
| Quick Ratio | 12.15 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -7.55% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -11.25% |
| Revenue Per Employee | $517,773 |
| Profits Per Employee | -$580,455 |
| Employee Count | 66 |
| Asset Turnover | 0.09 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, RNAC has paid $287,000 in taxes.
| Income Tax | 287,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.40% in the last 52 weeks. The beta is 0.83, so RNAC's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | -50.40% |
| 50-Day Moving Average | 13.37 |
| 200-Day Moving Average | 16.99 |
| Relative Strength Index (RSI) | 41.49 |
| Average Volume (20 Days) | 82,474 |
Short Selling Information
The latest short interest is 2.53 million, so 9.76% of the outstanding shares have been sold short.
| Short Interest | 2.53M |
| Short Previous Month | 2.38M |
| Short % of Shares Out | 9.76% |
| Short % of Float | 27.10% |
| Short Ratio (days to cover) | 21.21 |
Income Statement
In the last 12 months, RNAC had revenue of $34.17 million and -$38.31 million in losses. Loss per share was -$1.73.
| Revenue | 34.17M |
| Gross Profit | -15.87M |
| Operating Income | -44.36M |
| Pretax Income | -248.65M |
| Net Income | -38.31M |
| EBITDA | -42.24M |
| EBIT | -44.36M |
| Loss Per Share | -$1.73 |
Full Income StatementBalance Sheet
The company has $180.43 million in cash and $14.07 million in debt, giving a net cash position of $166.37 million or $6.41 per share.
| Cash & Cash Equivalents | 180.43M |
| Total Debt | 14.07M |
| Net Cash | 166.37M |
| Net Cash Per Share | $6.41 |
| Equity (Book Value) | -21.79M |
| Book Value Per Share | -0.84 |
| Working Capital | 170.12M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$30.87 million and capital expenditures -$9.57 million, giving a free cash flow of -$40.43 million.
| Operating Cash Flow | -30.87M |
| Capital Expenditures | -9.57M |
| Free Cash Flow | -40.43M |
| FCF Per Share | -$1.56 |
Full Cash Flow StatementMargins
Gross margin is -46.43%, with operating and profit margins of -129.81% and -112.11%.
| Gross Margin | -46.43% |
| Operating Margin | -129.81% |
| Pretax Margin | -111.27% |
| Profit Margin | -112.11% |
| EBITDA Margin | -123.59% |
| EBIT Margin | -129.81% |
| FCF Margin | n/a |
Dividends & Yields
RNAC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -326.98% |
| Shareholder Yield | -326.98% |
| Earnings Yield | -14.08% |
| FCF Yield | -14.86% |
Analyst Forecast
The average price target for RNAC is $41.00, which is 294.99% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $41.00 |
| Price Target Difference | 294.99% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 44.24% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on April 5, 2024. It was a reverse split with a ratio of 0.0333333:1.
| Last Split Date | Apr 5, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0333333:1 |
Scores
RNAC has an Altman Z-Score of -1.62 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.62 |
| Piotroski F-Score | 3 |